Filing Details
- Accession Number:
- 0001209191-21-056526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-16 21:30:38
- Reporting Period:
- 2021-09-14
- Accepted Time:
- 2021-09-16 21:30:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645569 | Dice Therapeutics Inc. | DICE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1356950 | Paul James Scopa | C/O Dice Therapeutics, Inc. 279 E. Grand Avenue, Suite 300, Lobby B South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-15 | 6,000 | $17.00 | 55,841 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-09-14 | 12,096 | $0.00 | 12,096 | $17.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-09-14 | 8,261 | $0.00 | 8,261 | $17.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-09-14 | 8,200 | $0.00 | 8,200 | $17.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-09-14 | 5,600 | $0.00 | 5,600 | $17.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,096 | 2031-09-14 | No | 4 | A | Direct | |
| 8,261 | 2031-09-14 | No | 4 | A | Direct | |
| 8,200 | 2031-09-14 | No | 4 | A | Direct | |
| 5,600 | 2031-09-14 | No | 4 | A | Direct |
Footnotes
- The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
- Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
- The option vests as to 1/36th of the total shares monthly, beginning November 8, 2020, subject to the Reporting Holder's continued service to the Registrant.
- The option vests as to 1/36th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continued service to the Registrant.
- The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant.
Billionaire Hedge Funds
